[1] 陈新谦,金有豫,汤光.新编药物学[M].17版,北京:人民卫生出版社,2011:500-501. [2] 赖根福,雷招宝.洛哌丁胺的不良反应与合理用药[J]. 山西医药杂志,2009, 17(20):951-952. [3] 王淑梅, 赵合兴. 洛哌丁胺不良反应[J]. 医药导报, 1997,(3) :141. [4] Acnp P V, Solik M M K, SHIV BAGGA M D, et al. Electrocardiographic Abnormalities, Malignant Ventricular Arrhythmias and Cardiomyopathy Associated with Loperamide Abuse[J/OL].(2016-09-05)[2016-09-22].http://onlinelibrary.wiley.com/doi/10.1111/jce.13052/epdf. [5] Eggleston W, Clark K H, Marraffa J M. Loperamide Abuse Associated With Cardiac Dysrhythmia and Death.[J/OL].(2016-04-29)[2016-09-25].http://www.west-info.eu/files/Annals-of-Emergency-Medicine-Loperamide-Abuse-Associated-With-Cardiac-Dysrhythmia-and-Death-20161.pdf. [6] Wightman R S, Hoffman R S, Howland M A, et al. Not your regular high: cardiac dysrhythmias caused by loperamide[J].Clin Toxicol (Phila) , 2016,54(5):454-458. [7] Mukarram O, Hindi Y, Catalasan G, et al. Loperamide Induced Torsades de Pointes: A Case Report and Review of the Literature[J/OL].(2016-04-26)[2016-09-26].https://www.researchgate.net/publication/295085010_Loperamide_Induced_Torsades_de_Pointes_A_Case_Report_and_Review_of_the_Literature. [8] O’Connell C W, Schricker A A, Schneir A B, et al. High Dose Loperamide Abuse associated Ventricular Arrhythmias[J].Heartrhythm Case Reports, 2016, 2(3):232-236. [9] Marraffa J M, Holland M G, Sullivan R W, et al. Cardiac conduction disturbance after loperamide abuse[J]. Clinical Toxicology, 2014, 52(9):952-957. [10] Enakpene E O, Riaz I B, Shirazi F M, et al. The Long QT Teaser: loperamide abuse[J]. American Journal of Medicine, 2015, 128(10):1083-6. [11] Marzec L N, Katz D F, Peterson P N, et al. Torsade de pointes associated with high-dose loperamide ingestion[J]. Journal of Innovations in Cardiac Rhythm Management, 2015, (6):1897-1899. [12] Spinner H L, Lonardo N W, Mulamalla R, et al. Ventricular Tachycardia Associated with High-Dose Chronic Loperamide Use[J]. Pharmacotherapy, 2015, 35(2):234-238. [13] Upadhyay A, Bodar V, Malekzadegan M, et al. Loperamide Induced Life Threatening Ventricular Arrhythmia[J/OL].(2016-07-28)[2016-09-25]. http://europepmc.org/backend/ptpmcrender.fcgi?accid=PMC4980497&blobtype=pdf. [14] Sehar T, Sadiq M. Coronary artery spasm after ingestion of Imodium (loperamide) in a 14-year-old boy[J]. Annals of Pediatric Cardiology, 2016, 9(2):158-160. [15] Eggleston W, Nacca N, Marraffa J M. Loperamide toxicokinetics:serum concentrations in the overdose setting.[J]. Clinical Toxicology, 2015, 53(5):1-2. [16] Center for Drug Evaluation. FDA Drug Safety Communication: FDA warns about serious heart problems with high doses of the antidiarrheal medicine loperamide (Imodium), including from abuse and misuse[EB/OL].(2016-06-07)[2016-09-16].http://www.fda.gov/downloads/Drugs/DrugSafety/UCM505108.pdf. [17] Lipski J, Stimmel B, Donoso E. The effect of heroin and multiple drug abuse on the electrocardiogram[J]. American Heart Journal, 1973, 86(5):663-668. [18] Katchman A N, Mcgroary K A, Kilborn M J, et al. Influence of Opioid Agonists on Cardiac Human Ether-a-go-go-related Gene K+ Currents[J]. Journal of Pharmacology & Experimental Therapeutics,2002, 303(303):688-694. [19] Ekins S, Balakin K V, Savchuk N, et al. Insights for human ether-a-go-go-related gene potassium channel inhibition using recursive partitioning and Kohonen and Sammon mapping techniques [J].Journal of Medicinal Chemistry, 2006, 49(17):5059-5071. [20] Baker D E. Loperamide: a pharmacological review[J]. Reviews in Gastroenterological Disorders, 2007, 7(Suppl3):11-18. [20] Gautret B, Schmitt H. Vagally mediated reflex and cardiac slowing induced by loperamide in rats[J]. European Journal of Pharmacology, 1985, 107(2):157-160. [22] Niemi M, Tornio A, Pasanen M K, et al. Itraconazole, gemfibrozil and their combination markedly raise the plasma concentrations of loperamide[J]. European Journal of Clinical Pharmacology, 2006,62(6):463-72. [23] Sadeque A J M, Christoph Wandel M D, He H, et al. Increased drug delivery to the brain by P-glycoprotein inhibition[J]. Clinical Pharmacology & Therapeutics, 2000, 68(3):231-237. [24] World Health Organization. Loperamide: voluntary withdrawal of infant formulations[J]. WHO Drug Information,1990,4(2):73-74. [25] Daniulaityte R, Carlson R, Falck R, et al. I just wanted to tell you that loperamide WILL WORK: a web-based study of extra-medical use of loperamide[J]. Drug Alcohol Depend, 2013,130(13):241-244. |